Breast Cancer

« Treatment »

Treatment for HER2-Positive Breast Cancer

Dr. Elizabeth Comen Memorial Sloan Kettering Cancer Center

Women who are diagnosed with HER2-positive breast cancer have high levels of the HER2 protein on the outside of their cancer cells. For patients with early-stage disease, meaning they have relatively small tumors and no lymph involvement, a number of HER2-directed therapies have dramatically changed the landscape. These include drugs like Herceptin and Perjeta.

According to Dr. Elizabeth Comen, a medical oncologist at Memorial Sloan Kettering Cancer Center and an advisor to SurvivorNet, there are also several drugs that have improved overall survival for patients with HER2-positive metastatic breast cancer.

Learn more about SurvivorNet's rigorous medical review process.


Dr. Elizabeth Comen serves as a medical advisor to SurvivorNet. She is a medical oncologist at Memorial Sloan Kettering Cancer Center. Read More

Treatment: Lymphedema

Lymphedema is a chronic swelling that can occur after breast cancer surgery and radiation.

Living

What is Lymphedema?

Dr. Dung Nguyen
Stanford Medicine
Treatment

Understanding and Treating Lymphedema

Dr. Dung Nguyen
Stanford Medicine